7Baggers

Sangamo Therapeutics Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -123.57-83.35-43.14-2.9237.377.52117.74157.96Milllion

Sangamo Therapeutics Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 2001-12-31 2001-09-30 2001-06-30 2001-03-31 2000-12-31 2000-09-30 2000-06-30 2000-03-31 
  revenue2,041,999 9,398,000 6,835,000 157,957,000 27,230,000 26,460,000 29,378,000 28,231,000 27,986,000 28,563,000 27,872,000 26,280,000 25,800,000 57,763,000 21,553,000 13,076,000 54,851,000 21,958,000 17,548,000 8,071,000 26,837,000 23,562,000 21,416,000 12,637,000 13,077,000 11,812,000 8,253,000 3,425,000 8,922,000 2,823,000 3,702,000 3,942,000 9,121,000 8,569,000 8,358,000 13,491,000 14,952,000 12,417,000 10,385,000 8,116,000 6,869,000 5,707,000 6,934,000 4,623,000 8,931,000 4,907,000 4,574,000 3,242,000 4,748,000 1,857,000 1,514,000 2,200,000 4,689,000 2,943,000 6,525,000 6,648,000 10,241,000 4,063,000 4,726,000 3,157,000 6,834,000 3,745,000 2,842,000 2,765,000 2,767,000 2,325,000 2,584,000 1,422,000 2,193,000 1,779,000 1,777,000 2,136,000 1,397,000 412,000 418,000 256,000 200,000 172,000 132,000 811,000 1,003,000 507,000 518,000 551,000 2,464,000 1,012,000 366,000 501,000 2,164,000 739,000 1,348,000 634,000 1,056,000 823,000 747,000 807,000 
  cost of revenue2,982,000 9,511,000 4,256,000 3,489,000 3,343,000 3,049,000 -1,000 -4,975,000 -111,000 -90,000 -887,000 
  gross profit-940,001 -113,000 2,579,000 154,468,000 23,887,000 23,411,000 29,378,000 28,231,000 27,986,000 28,563,000 27,872,000 26,280,000 25,800,000 57,763,000 21,553,000 13,076,000 54,851,000 21,958,000 17,548,000 8,071,000 26,837,000 23,562,000 21,416,000 12,637,000 13,077,000 11,812,000 8,253,000 3,425,000 8,922,000 2,823,000 3,702,000 3,942,000 9,121,000 8,569,000 8,358,000 13,491,000 14,952,000 12,417,000 10,385,000 8,116,000 6,869,000 5,707,000 6,934,000 4,623,000 8,932,000 4,907,000 4,574,000 3,242,000 4,748,000 1,857,000 1,514,000 2,200,000 4,689,000 2,943,000 6,525,000 6,648,000 10,241,000 4,063,000 4,726,000 3,157,000 6,834,000 3,745,000 2,842,000 2,765,000 2,767,000 2,325,000 2,584,000 1,422,000 2,193,000 1,779,000 1,777,000 2,136,000 1,397,000 412,000 418,000 256,000 200,000 172,000 132,000 811,000 1,003,000 507,000 518,000 551,000 2,464,000 1,012,000 366,000 501,000 2,164,000 739,000 1,348,000 634,000 6,031,000 934,000 837,000 1,694,000 
  operating expenses                                                                                                
  research and development51,206,000 57,089,000 63,046,000 63,216,000 66,179,000 65,116,000 60,019,000 58,584,000 51,801,000 62,498,000 60,086,000 56,434,000 52,358,000 45,287,000 41,523,000 41,479,000 38,329,000 36,288,000 36,455,000 34,850,000 33,254,000 28,810,000 29,255,000 23,547,000 19,377,000 18,425,000 14,984,000 12,942,000 13,890,000 17,008,000 19,454,000 15,266,000 19,906,000 16,694,000 15,618,000 14,980,000 14,991,000 16,290,000 13,430,000 12,033,000 10,778,000 8,703,000 9,278,000 8,220,000 9,281,000 7,570,000 7,574,000 7,283,000 7,878,000 7,839,000 8,119,000 8,262,000 9,873,000 8,769,000 7,147,000 7,365,000 8,685,000 6,166,000 6,877,000 7,256,000 6,737,000 7,563,000 8,286,000 8,646,000 7,904,000 5,916,000 6,309,000 5,430,000 10,057,000 3,853,000 4,028,000 3,589,000 2,972,000 3,121,000 2,726,000 2,595,000 2,333,000 3,634,000 2,268,000 2,811,000 2,287,000 2,157,000 3,056,000 2,687,000 3,574,000 3,322,000 3,109,000 3,358,000 6,364,000 3,892,000 3,050,000 2,210,000 5,320,000 1,896,000 1,738,000 2,828,000 
  sales, general and administrative                                                                                                
  total operating expenses61,423,000 71,007,000 79,060,000 81,352,000 82,622,000 81,354,000 75,112,000 73,492,000 67,885,000 76,999,000 76,572,000 72,582,000 69,232,000 61,464,000 59,450,000 57,598,000 53,382,000 51,206,000 51,052,000 51,968,000 47,609,000 39,803,000 40,556,000 33,634,000 26,843,000 24,847,000 21,021,000 20,217,000 18,752,000 22,029,000 30,544,000 20,623,000 24,794,000 21,254,000 20,635,000 19,712,000 19,321,000 20,021,000 17,402,000 15,677,000 14,983,000 11,866,000 12,402,000 11,528,000 12,300,000 10,709,000 10,318,000 10,525,000 11,113,000 11,431,000 11,795,000 11,801,000 13,027,000 11,658,000 10,404,000 10,651,000 12,656,000 8,867,000 9,884,000 10,182,000 9,033,000 10,127,000 10,831,000 11,573,000 10,374,000 7,644,000 8,422,000 7,429,000 11,999,000 5,422,000 5,849,000 5,344,000 4,317,000 4,204,000 3,874,000 3,836,000 3,599,000 4,847,000 -3,265,000 3,990,000 3,032,000 3,473,000 4,221,000 3,622,000 3,499,000 22,433,000 4,343,000 5,262,000 6,138,000 5,867,000 4,603,000 3,657,000 9,909,000 4,039,000 3,549,000 4,482,000 
  operating income-62,363,000 -106,408,000 -123,572,000 135,176,000 -55,392,000 -54,894,000 -45,734,000 -45,261,000 -39,899,000 -48,436,000 -48,700,000 -46,302,000 -43,432,000 -3,701,000 -37,897,000 -44,522,000 1,469,000 -29,248,000 -33,504,000 -43,897,000 -20,772,000 -16,241,000 -19,140,000 -20,997,000 -13,766,000 -13,035,000 -12,768,000 -16,792,000 -9,830,000 -19,206,000 -26,842,000 -16,681,000 -15,673,000 -12,685,000 -12,277,000 -6,221,000 -4,469,000 -7,654,000 -7,047,000 -7,611,000 -8,174,000 -6,159,000 -5,468,000 -6,905,000 -3,369,000 -5,802,000 -5,744,000 -7,283,000 -6,365,000 -9,574,000 -10,281,000 -9,601,000 -8,338,000 -8,715,000 -3,879,000 -4,003,000 -2,415,000 -4,804,000 -5,158,000 -7,025,000 -2,199,000 -6,382,000 -7,989,000 -8,808,000 -7,607,000 -5,319,000 -5,838,000 -6,007,000 -9,806,000 -3,643,000 -4,072,000 -3,208,000 -2,920,000 -3,792,000 -3,456,000 -3,580,000 -3,399,000 -4,675,000 3,397,000 -3,179,000 -2,029,000 -2,966,000 -3,703,000 -3,071,000 -1,035,000 -21,602,000 -3,977,000 -4,951,000 -3,974,000 -18,190,000 -3,255,000 -3,023,000 -3,878,000 -3,105,000 -2,712,000 -2,788,000 
  net income-60,296,000 -104,163,000 -114,506,000 21,133,000 -51,973,000 -53,155,000 -43,173,000 -43,977,000 -37,496,000 -47,688,000 -47,169,000 -45,933,000 -40,604,000 -1,550,000 -35,929,000 -42,913,000 4,555,000 -27,307,000 -30,284,000 -42,150,000 -18,664,000 -12,843,000 -16,640,000 -20,187,000 -13,091,000 -12,354,000 -12,491,000 -16,632,000 -9,624,000 -18,965,000 -26,575,000 -16,494,000 -14,013,000 -9,245,000 -12,126,000 -5,319,000 -4,319,000 -7,545,000 -6,981,000 -7,572,000 -8,144,000 -6,145,000 -5,450,000 -6,885,000 -3,478,000 -5,790,000 -5,728,000 -7,268,000 -6,359,000 -9,554,000 -10,259,000 -9,578,000 -8,321,000 -8,695,000 -3,860,000 -3,978,000 -2,393,000 -4,851,000 -4,511,000 -6,832,000 -2,574,000 -6,340,000 -7,419,000 -7,972,000 -6,672,000 -4,268,000 -5,181,000 -5,359,000 -8,948,000 -2,845,000 -3,327,000 -2,744,000 -2,693,000 -3,667,000 -3,380,000 -3,553,000 -3,043,000 -4,571,000 -3,262,000 -2,942,000 -1,680,000 -2,584,000 -3,274,000 -2,895,000 -706,000 -20,940,000 -3,631,000 -4,487,000 -3,366,000 -17,407,000 -2,414,000 -2,062,000 -2,805,000 -1,818,000 -1,725,000 -2,718,000 

We provide you with 20 years income statements for Sangamo Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Sangamo Therapeutics stock. Explore the full financial landscape of Sangamo Therapeutics stock with our expertly curated income statements.

The information provided in this report about Sangamo Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.